Today, we feature Oculus Innovative Sciences Inc (NASDAQ: OCLS), a global healthcare company, as the top momentum gainer since the stock gained more than 13% during the last two consecutive trading days with far more shares changing hands than in a normal session. OCLS was among the top gainers in the U.S. healthcare space after gaining 18.7% during the last session and closed at $5.84 while recording significant volumes of 3.5 million shares. During the past 5 trading sessions, OCLS surged 49.7% with daily average traded volumes of 1.3 million shares. The stock witnessed a strong momentum in the past one month after rallying over 53% with daily average volume of 479,865 shares. Recently, Seeking Alpha’s John H. Ford noted that OCLS’s subsidiary – Ruthigen’s IPO will act as a strong catalyst for the price appreciation. Positive clinical data for OCLS products provides high probability of FDA approvals. Oculus and Ruthigen own the patents to a technology that could revolutionize how infections are prevented and treated.
Company Description:
Oculus Innovative Sciences Inc (NASDAQ: OCLS) develops and manufactures products to prevent and eliminate infections in chronic and acute wounds.
1-Year Stock Chart:
Source: Bloomberg
